Stock Screener App

Frei -

Installieren

9.1563

1.60% -0.2337

Puma Biotechnology Inc (PBYI)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Puma Biotechnology Inc Aktie (PBYI) Neueste Nachrichten

Puma Biotechnology: NERLYNX Funds Their Potential Next Oncology Franchise (NASDAQ:PBYI) - Seeking Alpha

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)September 3, 2026 - BioSpace

Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4) - TradingView

InvestingPro’s fair value model spotted Puma Biotech’s 95% rally By Investing.com - Investing.com

PBYI | PUMA BIOTECHNOLOGY INC FinancialsRevenue Breakdown - Quiver Quantitative

Puma (PBYI) Latest Quarter: The Available Earnings Metric Delivers a Beat; Investor Response: The Stock Ends Down 4.00% for the Current SessionEarnings Turnaround - vinanet.vn

Puma Biotechnology (PBYI) Q2 2026 Earnings Call Transcript - AOL.com

Puma (PBYI) Latest Quarter: EPS Lands Above Forecast in the Current Update; Trading Move: Shares Move 4.76% Up in the Latest SessionEPS Growth Report - vinanet.vn

Puma Biotechnology (NASDAQ:PBYI) Upgraded at Wall Street Zen - MarketBeat

Puma Biotechnology Inc (PBYI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Is Puma Biotechnology (PBYI) a Great Value Stock Right Now? - Yahoo Finance

Puma Biotechnology, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:PBYI) 2026-08-10 - Seeking Alpha

Puma Biotechnology Reports $56.5M Revenue and Profitability in Q2 - sekbernews.id

Puma Biotechnology (PBYI) Stock Jumps On Profit Strength As Earnings Outlook Fades - Sahm

Puma Biotechnology (NASDAQ:PBYI) Issues Earnings Results, Beats Expectations By $0.15 EPS - MarketBeat

Puma Biotech earnings beat by $0.16, revenue topped estimates - Investing.com Nigeria

TD Cowen Forecasts Strong Price Appreciation for Puma Biotechnology (NASDAQ:PBYI) Stock - marketbeat.com

Transcript : Puma Biotechnology, Inc., Q2 2026 Earnings Call, Aug 06, 2026 - marketscreener.com

PBYI Q2 Earnings & Sales Beat Estimates, 2026 Guidance Raised - Yahoo Finance

Puma Biotechnology, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance

Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares - Investing.com

Puma Biotechnology Q2 Earnings Call Highlights - MarketBeat

Puma Biotechnology Inc (PBYI) (Q2 2026) Earnings Call Highlights: Debt-Free Status and Raised ... - finance.yahoo.com

Puma Biotech (PBYI) Q2 Earnings and Revenues Top Estimates - Yahoo Finance

Earnings call transcript: Puma Biotechnology tops Q2 2026 estimates as profit returns - Investing.com

Puma Biotechnology Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Puma Biotech: Q2 Earnings Snapshot - aol.com

PUMA BIOTECHNOLOGY, INC. 2026: Revenue $56.5M, EPS $0.16— 10-Q Summary - TradingView

Puma Biotechnology Reports Second Quarter 2026 Financial Results - marketscreener.com

Puma Biotechnology, Inc. Provides Earnings Guidance for the Third Quarter of 2026 - marketscreener.com

Puma Biotechnology Inc expected to post earnings of 4 cents a shareEarnings Preview - TradingView

Puma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2025 Financial Results - The National Law Review

Puma Biotechnology (PBYI) Gains 1.43% to $7.8, Holds Above Key Support at $7.41Momentum Breakout Ideas - dars.gov.et

Renaissance Technologies LLC Cuts Position in Puma Biotechnology, Inc. $PBYI - MarketBeat

Earnings Preview: Puma Biotech (PBYI) Q2 Earnings Expected to Decline - Eastern Progress

Puma Biotechnology (PBYI) Slips 1.88% as Stock Tests Key Support LevelsDividend Stock Picks - vinanet.vn

Puma Biotechnology Inc Revenue Breakdown – NASDAQ:PBYI - TradingView

Puma Biotechnology Inc (PBYI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Puma Biotechnology Inc (PBYI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Puma Biotechnology Inc (PBYI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

ETFs Investing in Puma Biotechnology, Inc. Stocks - TradingView

PBYI|Puma Biotechnology Inc|Price:7.980|Chg%:-0.030 - TradingKey

Puma Biotechnology to Host Conference Call to Discuss Second Quarter 2026 Financial Results - WBOC TV

Puma Stock Puma Biotechnology Inc Discount Puma Biotechnology Acquisition Outlet Online PUMA Biotechnology Form S - มูลนิธิเพื่อผู้บริโภค มพบ.

Puma Biotechnology’s Douglas M. Hunt sells $69,904 in shares By Investing.com - Investing.com Nigeria

Puma biotechnology CFO Maximo Nougues sells $77,556 in stock By Investing.com - Investing.com South Africa

Form 4 Puma Biotechnology Inc For: 8 July By Investing.com - Investing.com Nigeria

Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 By Investing.com - Investing.com South Africa

Puma Biotechnology (PBYI) CEO sells 44,058 shares under 10b5-1 plan - Stock Titan

Puma Biotechnology (PBYI) CFO sells 9,386 shares in 10b5-1 trade - Stock Titan

Alan Auerbach, Puma Biotechnology president and CEO, sells $364,051 - Investing.com

Form 144 PUMA BIOTECHNOLOGY For: 6 July By Investing.com - Investing.com Nigeria

[144] PUMA BIOTECHNOLOGY, INC. SEC Filing - Stock Titan

Puma Biotechnology (PBYI) Faces Resistance as Shares Pull Back Toward Key SupportMarket Neutral Pair - dars.gov.et

Price to sales forward of Puma Biotechnology Inc – NASDAQ:PBYI - TradingView

PBYIPuma Biotechnology Inc Latest SEC Filings - Finviz

Puma Biotechnology highlights targeted cancer therapies as investors watch Nasdaq-listed PBYI - Ad-hoc-news.de

PBYI News | PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) - ChartMill

RPRX

$60.22

0.63%

INSM

$129.44

3.49%

ROIV

$41.41

0.30%

ALNY

$255.14

1.53%

ONC

$349.34

0.65%

RVMD

$209.18

0.88%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters